Loss of systemic endothelial function post-PCI

References

• Blum A, Schneider DJ, Sobel BE, Dauerman HL. Endothelial dysfunction and inflammation after percutaneous coronary intervention. Am J Card. 2004; 94: 1420–3
   PubMedGoogle Scholar
• Hojo Y, Ikeda U, Katsuki TA, Shimada K. Release of endothelin1 and angiotensin II induced by percutaneous transluminal coronary angioplasty. Catheterization and Cardiovasc Interv. 2000; 51: 41–9
   Google Scholar
• Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol. 1992; 3: 58–65
   PubMed Web of Science ®Google Scholar
• Dalby MCD, Davidson SJ , Burman JF, Clague J, Sigwart U, Davies SW. Systemic platelet effect of contrast media: implications for cardiologic research and clinical practice. Am Heart J. 2002;143.
   Google Scholar
• Zhan X, Agrawal DK, Thorpe PE. Effect of iodinated contrast media on neutrophil adhesion to cultured endothelial cells. J Vasc Interv Radiol. 1998; 9: 808–16
   PubMedGoogle Scholar
• Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 2005; 111: 70–5
   PubMed Web of Science ®Google Scholar
• Kitta Y, Nakamura T, Kodama Y, Takano H, Umetani K, Fujioka D, et al. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol. 2005; 46: 648–55
   PubMed Web of Science ®Google Scholar
• Kurz T, Schafer U, Dendorfer A, Hartmann F, Raasch W, Tolg R, et al. Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. Am J Cardiol. 2001; 88: 1351–7
   PubMedGoogle Scholar
• Lincoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI, Barnathan ES, Patel KK, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001; 104: 163
   PubMed Web of Science ®Google Scholar
• George J, Shmuel SB, Roth A, Herz I, Izraelov S, Deutsch V, et al. Arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty. Atherosclerosis 2004; 174: 323–7
   PubMedGoogle Scholar
• Lee TM, Lin MS, Tsai CH, Chang NC. Effect of ischaemic preconditioning on regional release of inflammatory markers. Clin Sci. 2005; 109: 267–76
   Google Scholar
• Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain B-type natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol. 2000; 23: 776–80
   PubMedGoogle Scholar
• Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest. 1991; 87: 1999–2004
   PubMed Web of Science ®Google Scholar
• Yoshizumi M, Tsuji H, Nishimura H, Masuda H, Kunieda Y, Kawano H, et al. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells. Thromb Haemost. 1999; 82: 1497–503
   PubMedGoogle Scholar
• Celermajer DS, Sorensen KE, Gooch V M, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–5
   PubMed Web of Science ®Google Scholar
• Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314–9
   PubMed Web of Science ®Google Scholar
• Gorski TP, Campbell DJ. Angiotensin-converting enzyme determination in plasma during therapy with converting enzyme inhibitor: two methods compared. Clin Chem. 1991; 37: 1390–3
   PubMedGoogle Scholar
• Chien Tzu-I, Chen Hui-hou, Kao Jau-Tsuen. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP. Clin Chim Acta 2006;369:95.
   PubMedGoogle Scholar
• Win Yan, Fage Wu, Morser J, Zingyu Wu. Corin, a transmembrane cardiac serine protease, acts as a natriuretic peptide converting enzyme. Proc Natl Acad Sci. 2000; :8525–9.
   PubMedGoogle Scholar
• Ahluwalia A, MacAllister RJ, Hobbs AJ. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res Cardiol. 2004; 99: 83–9
   PubMed Web of Science ®Google Scholar
• Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004; 44: 733–9
   PubMed Web of Science ®Google Scholar
• Blum A, Schneider DJ, Sobel BE, Dauerman HL. Endothelial dysfunction and inflammation after percutaneous coronary intervention. Am J Cardiol. 2004; 94: 1420–3
   PubMedGoogle Scholar
• Vaziri ND, Wang XQ. cGMP-Mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 1999;:1237–41.
   PubMedGoogle Scholar
• Gori T, Burstein JM, Ahmed S, Miner SE, Al-Hesayen A, Kelly S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: A human in vivo study. Circulation 2001; 140: 1119–23
   Google Scholar
• Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in respect to drugs. Nitric Oxide Biol Chem. 2002; 7: 149–64
   PubMed Web of Science ®Google Scholar
• Goetze JP, Yongzhong W, Rehfeld JF, Jorgensen E, Kastrup J. Coronary angiography transiently increases plasma pro-B-type natriuretic peptide. Eur Heart J. 2004; 25: 759–64
   PubMedGoogle Scholar
• Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 1991; 69: 491–500
   PubMed Web of Science ®Google Scholar
• Bordenave L, Georges A, Bareille R, Conrad V, Villars F, Amedee J. Human bone marrow endothelial cells: a new identified source of B-type natriuretic peptide. Peptides 2002; 23: 935–40
   PubMedGoogle Scholar
• Suzuki E, Hirata Y, Kohmoto O, Sugimoto T, Hayakawa H, Matsuoka H, et al. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res. 1992; 71: 1039–48
   PubMedGoogle Scholar
• Gelfand RA, Frank HJ, Levin E, Pedram A. Brain and atrial natriuretic peptides bind to common receptors in brain capillary endothelial cells. Am J Physiol. 1991; 261: E183–9
   Google Scholar
• Emori T, Hirata Y, Imai T, Eguchi S, Kanno K, Marumo F. Cellular mechanisms of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 1993; 133: 2474–80
   PubMed Web of Science ®Google Scholar
• Murohara T, Kugiyama K, Ota Y, Doi H, Ogata N, Ohgushi M, et al. Effects of atrial and brain natriuretic peptides on lysophosphatidylcholine-mediated endothelial dysfunction. J Cardiovasc Pharmacol. 1999; 34: 870–8
   PubMedGoogle Scholar